Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
Pharmacol Res
; 148: 104406, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31442576
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Drug Resistance, Neoplasm
/
Cell Proliferation
/
Epithelial-Mesenchymal Transition
/
ADAM17 Protein
/
Lung Neoplasms
/
Neoplasm Metastasis
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2019
Type:
Article
Affiliation country:
China